Anaplastic lymphoma kinase (ALK)-rearranged pulmonary pleomorphic carcinoma successfully treated with crizotinib

Pulmonary pleomorphic carcinoma (PPC) is rare, and the response of patients to conventional chemotherapy is very poor. Here we present a patient with anaplastic lymphoma kinase (ALK)-rearranged advanced PPC treated with crizotinib. Computed tomography revealed a mass in the left upper lung of a nons...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Liping, Huang, Fuxi, Chen, Fang, He, Yan, Hu, Jiazhu, Cao, Xiaolong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134637/
https://www.ncbi.nlm.nih.gov/pubmed/29310482
http://dx.doi.org/10.1177/0300060517748262

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6134637/
https://www.ncbi.nlm.nih.gov/pubmed/29310482
http://dx.doi.org/10.1177/0300060517748262

Ejemplares similares